SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System.


Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
10 2021
Historique:
accepted: 29 04 2021
pubmed: 14 5 2021
medline: 8 3 2022
entrez: 13 5 2021
Statut: ppublish

Résumé

Astrocytes, the main supportive cell type of the brain, show functional impairments upon ageing and in a broad spectrum of neurological disorders. Limited access to human astroglia for pre-clinical studies has been a major bottleneck delaying our understanding of their role in brain health and disease. We demonstrate here that functionally mature human astrocytes can be generated by SOX9 overexpression for 6 days in pluripotent stem cell (PSC)-derived neural progenitor cells. Inducible (i)SOX9-astrocytes display functional properties comparable to primary human astrocytes comprising glutamate uptake, induced calcium responses and cytokine/growth factor secretion. Importantly, electrophysiological properties of iNGN2-neurons co-cultured with iSOX9-astrocytes are indistinguishable from gold-standard murine primary cultures. The high yield, fast timing and the possibility to cryopreserve iSOX9-astrocytes without losing functional properties makes them suitable for scaled-up production for high-throughput analyses. Our findings represent a step forward to an all-human iPSC-derived neural model for drug development in neuroscience and towards the reduction of animal use in biomedical research.

Identifiants

pubmed: 33982246
doi: 10.1007/s12015-021-10179-x
pii: 10.1007/s12015-021-10179-x
pmc: PMC8553725
doi:

Substances chimiques

SOX9 Transcription Factor 0
SOX9 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1855-1873

Informations de copyright

© 2021. The Author(s).

Références

EMBO Rep. 2018 Nov;19(11):
pubmed: 30166336
Stem Cell Reports. 2017 Dec 12;9(6):1885-1897
pubmed: 29153989
Nat Biotechnol. 2019 Mar;37(3):267-275
pubmed: 30804533
Neuron. 2017 Aug 16;95(4):779-790.e6
pubmed: 28817799
Trends Neurosci. 1997 Dec;20(12):570-7
pubmed: 9416670
Exp Neurol. 2018 Nov;309:23-31
pubmed: 30044944
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Alzheimers Dement. 2018 Oct;14(10):1261-1280
pubmed: 30036493
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4148-53
pubmed: 11259680
J Mass Spectrom. 1996 Mar;31(3):255-62
pubmed: 8799277
Brain Struct Funct. 2017 Jul;222(5):2017-2029
pubmed: 28280934
PLoS One. 2013 Nov 07;8(11):e80574
pubmed: 24348912
Sci Rep. 2016 Nov 07;6:36529
pubmed: 27819315
BMC Bioinformatics. 2011 Dec 17;12:480
pubmed: 22177264
Neuroscience. 1996 Apr;71(3):871-83
pubmed: 8867055
Methods. 2016 May 15;101:113-24
pubmed: 26626326
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Neuron. 2008 Sep 25;59(6):932-46
pubmed: 18817732
Nat Commun. 2017 May 11;8:15267
pubmed: 28492237
Genes Dev. 2003 Jul 1;17(13):1677-89
pubmed: 12842915
Brain Res Rev. 2010 May;63(1-2):39-46
pubmed: 19931561
Cells. 2019 Feb 20;8(2):
pubmed: 30791579
Nat Methods. 2018 Sep;15(9):693-696
pubmed: 30127505
Methods Mol Biol. 2019;1862:53-66
pubmed: 30315459
Stem Cells Transl Med. 2019 Dec;8(12):1272-1285
pubmed: 31631575
J Cell Sci. 2019 Feb 1;132(3):
pubmed: 30617110
Prog Neurobiol. 2008 Dec 11;86(4):342-67
pubmed: 18948166
Stem Cell Reports. 2018 Feb 13;10(2):655-672
pubmed: 29337119
Nat Protoc. 2020 Nov;15(11):3716-3744
pubmed: 33097924
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Brain Pathol. 2018 May;28(3):372-387
pubmed: 29740942
Glia. 2008 May;56(7):734-49
pubmed: 18293404
Stem Cells. 2013 Apr;31(4):741-51
pubmed: 23307615
Stem Cell Reports. 2020 Jul 14;15(1):38-51
pubmed: 32502466
Front Mol Neurosci. 2017 Dec 19;10:427
pubmed: 29311817
Stem Cell Reports. 2019 Feb 12;12(2):213-229
pubmed: 30639209
Nat Commun. 2017 Oct 11;8(1):861
pubmed: 29021520
Acta Neuropathol Commun. 2018 Aug 8;6(1):74
pubmed: 30089511
J Neurosci. 2009 Mar 11;29(10):3276-87
pubmed: 19279265
Bioinformatics. 2007 Nov 1;23(21):2881-7
pubmed: 17881408
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Neurochem Res. 2013 Jun;38(6):1260-5
pubmed: 23519933
Cell Rep. 2019 May 14;27(7):2199-2211.e6
pubmed: 31091456
Bioinformatics. 2009 Oct 1;25(19):2607-8
pubmed: 19654119
Front Aging Neurosci. 2018 Oct 26;10:337
pubmed: 30416441
Neuron. 2020 Aug 5;107(3):436-453.e12
pubmed: 32485136
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Stem Cell Reports. 2019 Feb 12;12(2):201-212
pubmed: 30639213
Stem Cell Reports. 2018 Nov 13;11(5):1199-1210
pubmed: 30409508
Sci Rep. 2019 Nov 15;9(1):16944
pubmed: 31729450
J Neurosci. 2015 Nov 11;35(45):15199-213
pubmed: 26558789
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Stem Cell Reports. 2015 Jan 13;4(1):25-36
pubmed: 25556566
Biomaterials. 2015 Feb;42:134-43
pubmed: 25542801
Nat Rev Neurosci. 2018 Jul;19(7):393-403
pubmed: 29777182
Stem Cell Reports. 2015 Nov 10;5(5):918-931
pubmed: 26455413
Metab Eng. 2017 Sep;43(Pt B):187-197
pubmed: 27847310
Stem Cell Reports. 2018 Oct 9;11(4):998-1008
pubmed: 30269954
Front Endocrinol (Lausanne). 2013 Aug 15;4:102
pubmed: 23966981

Auteurs

Katrien Neyrinck (K)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. katrien.neyrinck@kuleuven.be.

Johanna Van Den Daele (J)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. johanna.vandendaele@kuleuven.be.

Tim Vervliet (T)

Laboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Jonathan De Smedt (J)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.

Keimpe Wierda (K)

Electrophysiology Expert Unit, VIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.

Melissa Nijs (M)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.

Tom Vanbokhoven (T)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.

Astrid D'hondt (A)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.

Mélanie Planque (M)

Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncoloy, KU Leuven and Leuven Cancer Institute (LKI), Leuven, 3000, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, 3000, Belgium.

Sarah-Maria Fendt (SM)

Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncoloy, KU Leuven and Leuven Cancer Institute (LKI), Leuven, 3000, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, 3000, Belgium.

Pei-Yu Shih (PY)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Frederik Seibt (F)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Juan Pita Almenar (JP)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Mohamed Kreir (M)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Devesh Kumar (D)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Vania Broccoli (V)

Division of Neuroscience, IRCCS, San Raffaele Scientific Hospital, 20132, Milan, Italy.
Institute of Neuroscience, National Research Council (CNR), 20129, Milan, Italy.

Geert Bultynck (G)

Laboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Andreas Ebneth (A)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Alfredo Cabrera-Socorro (A)

Division of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.

Catherine Verfaillie (C)

Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. catherine.verfaillie@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH